SKLKY yields 0.81% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, SKLKY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SKLKY + PFE for your $10,000?
Shinsei Bank, Limited provides various banking and financial products and services to individual customers, corporations, public-sector entities, and financial institutions in Japan. It offers Yen/foreign currency deposits, and structured deposits; home mortgages; corporate loans, finance for start-up, real estate non-recourse finance, project finance, renewable energy finance, acquisition finance, ship finance, healthcare finance, sustainable finance/impact finance, M&A related finance, and specialty finance; and loan syndication. The company also provides foreign exchange and derivatives, M&A advisory, credit trading, private equity, business succession and change/closure support services, and wealth management, as well as prepaid and credit cards. In addition, it engages in the provision of trust services, leasing related financial products and services, equity related and other capital markets transactions, securities, asset and wealth management, unsecured loans, housing loans, investment trusts, brokerage, life and non-life insurance, consumer finance products and services, credit guarantee services, installment sales finance, credit cards, loan and payment services, and treasury services. The company was formerly known as The Long-Term Credit Bank of Japan, Limited and changed its name to Shinsei Bank, Limited in June 2000. Shinsei Bank, Limited was incorporated in 1952 and is headquartered in Tokyo, Japan.
Full SKLKY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.